These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10426160)

  • 41. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients.
    Tornatore KM; Biocevich DM; Reed K; Tousley K; Singh JP; Venuto RC
    Transplantation; 1995 Mar; 59(5):729-36. PubMed ID: 7886801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
    Saari TI; Grönlund J; Hagelberg NM; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2010 Apr; 66(4):387-97. PubMed ID: 20076952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
    Lilja JJ; Backman JT; Laitila J; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T; Shimizu M; Sugawara K; Tateishi T
    Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
    Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
    Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendan.
    Antila S; Honkanen T; Lehtonen L; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):446-9. PubMed ID: 9726699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
    Kivistö KT; Wang JS; Backman JT; Nyman L; Taavitsainen P; Anttila M; Neuvonen PJ
    Eur J Clin Pharmacol; 2001 Apr; 57(1):37-42. PubMed ID: 11372588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine.
    Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Pharmacol Toxicol; 2001 Apr; 88(4):187-91. PubMed ID: 11322176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Itraconazole increases serum digoxin concentration.
    Partanen J; Jalava KM; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):274-6. PubMed ID: 8936563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
    Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of itraconazole on the pharmacokinetics of imidafenacin in healthy subjects.
    Ohno T; Nakayama K; Nakade S; Kitagawa J; Ueda S; Miyabe H; Miyata Y; Ohnishi A
    J Clin Pharmacol; 2008 Mar; 48(3):330-4. PubMed ID: 18218784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of itraconazole on the pharmacokinetics of rosuvastatin.
    Cooper KJ; Martin PD; Dane AL; Warwick MJ; Schneck DW; Cantarini MV
    Clin Pharmacol Ther; 2003 Apr; 73(4):322-9. PubMed ID: 12709722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine.
    Isohanni MH; Neuvonen PJ; Olkkola KT
    Pharmacol Toxicol; 1999 Mar; 84(3):143-6. PubMed ID: 10193676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of the antimycotic itraconazole on the pharmacokinetics and pharmacodynamics of diazepam.
    Ahonen J; Olkkola KT; Neuvonen PJ
    Fundam Clin Pharmacol; 1996; 10(3):314-8. PubMed ID: 8836707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.
    Luurila H; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers.
    Aymard G; Warot D; Démolis P; Giudicelli JF; Lechat P; Le Guern ME; Alquier C; Diquet B
    Pharmacol Toxicol; 2003 Jun; 92(6):279-86. PubMed ID: 12787260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.